Insider filing · RARE
Erik Harris
EVP & Chief Commercial Officer
profile →
Ultragenyx Pharmaceutical Inc.
RARE · Healthcare · 28 filings in 24 months
ticker →
Erik Harris sold $636K of Ultragenyx Pharmaceutical (RARE)
Executed Mar 3 2025, disclosed Mar 4 2025, 1 day later.
Value, as filed
$636K
15,103 sh × $42.10
Executed
Mar 3 2025
the trade date, as filed
Disclosed
Mar 4 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
EHErik Harris (EVP & Chief Commercial Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Ultragenyx Pharmaceutical Inc. (RARE). The largest single filing was $240K of RARE (10,539 sh × $22.80, as filed), executed Mar 2.
The name
RAREHealthcare · Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Erik Harris in RARE
RARESALE
Ultragenyx Pharmaceutical Inc.
$240K10,539 sh × $22.80
Exec Mar 2
Filed Mar 3 · 5:30 PM ET